Submit Manuscript
[section_quick_nav]
[article_type_date]

Evaluation of Response and Toxicity of Pemetrexed-Carboplatin Versus Paclitaxel-Carboplatin as First-Line Treatment in Metastatic Non-Squamous Non-Small Cell Lung Cancer

[display_authors]

1* Medical Officer National Institute of Cancer Research & Hospital, Dhaka

2 Department of Clinical Oncology Bangabandhu Sheikh Mujib Medical University, Dhaka

3 Department of Radiotherapy, Dhaka Medical College Hospital, Dhaka

4 Department of Radiotherapy, Shaheed Ziaur Rahman Medical College Hospital, Bogura

5 Department of Public Health North South University

Citation: Sarkar, U. K., Alam, S., Hoque, A., Sarker, N. K., & Mahmud, T. (2025). Evaluation of Response and Toxicity of Pemetrexed-Carboplatin Versus Paclitaxel- Carboplatinas First-Line Treatment in Metastatic Non-Squamous Non-Small Cell Lung Cancer, Chronicles of Clinical Reviews and Case Reports, The Geek Chronicles, 1, 1-9.
Copyright: © 2025 U Kumar Sarkar, this is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
[display_pdf_buttons]
Received On
 February 17, 2025
Accepted On
 March 5, 2025
Published On
 March 15, 2025
[display_sections]
[display_pdf_buttons]